Stockpolly
Search
RGC · NASDAQ · Drug Manufacturers - Specialty & Generic

Regencell Bioscience (RGC)

Develops standardized traditional Chinese medicine formulas for ADHD and autism spectrum disorder.

$6.30
Pre-market+0.03 (+0.48%)
At close$6.27(+14.00%)
Watchlist

In millions of USD, except per-share figures

In millionsQ4 FY20Jun 2020Q2 FY21Dec 2020Q4 FY21Jun 2021Q2 FY22Dec 2021Q4 FY22Jun 2022Q2 FY23Dec 2022Q4 FY23Jun 2023Q2 FY24Dec 2023Q4 FY24Jun 2024Q2 FY25Dec 2024Q4 FY25Jun 2025Q2 FY26Dec 2025
Revenue0000−2,3420000000
Cost of revenue000010100000
Gross profit0000−2,3420−100000
000433——0225
Research & development000111———100
000322———115
Selling & marketing000000———000
General & administrative000000———110
Operating income000−4−4−3——0−2−2−5
00−1−2−4−2———000
Other non-operating income001242110000
Income before tax00−1−4−4−3——0−2−2−5
Income tax expense000000——0000
Net income from continuing operations00−1−5−6−5−4−10−2−2−5
Discontinued operations000222110000
Other adjustments001000——0000
Net income000−4−4−3——0−2−2−5
EPS, basic−$0.00−$0.00−$0.00−$0.01−$0.01−$0.01−$0.01−$0.00−$0.00−$0.00−$0.00−$0.01
EPS, diluted−$0.00−$0.00−$0.00−$0.01−$0.01−$0.01−$0.01−$0.00−$0.00−$0.00−$0.00−$0.01
Weighted average shares, basic380380380493494494494494494494494494
Weighted average shares, diluted380380380493494494494494494494494494
EBITDA00−1−5−5−5−3—0−2−2−5
Depreciation & amortization000010———000
EBIT00−1−5−6−5−4−10−2−2−5